Literature DB >> 10748022

Saxiphilin, a saxitoxin-binding protein with two thyroglobulin type 1 domains, is an inhibitor of papain-like cysteine proteinases.

B Lenarcic1, G Krishnan, R Borukhovich, B Ruck, V Turk, E Moczydlowski.   

Abstract

The type 1 domain of thyroglobulin is a protein module (Thyr-1) that occurs in a variety of secreted and membrane proteins. Several examples of Thyr-1 modules have been previously identified as inhibitors of the papain family of cysteine proteinases. Saxiphilin is a neurotoxin-binding protein from bullfrog and a homolog of transferrin with a pair of such Thyr-1 modules located in the N-lobe. Saxiphilin is now characterized as a potent inhibitor of three cysteine proteinases as follows: papain, human cathepsin B, and cathepsin L. The stoichiometry of enzyme inhibition reveals that both Thyr-1 domains of saxiphilin inhibit papain (apparent K(i) = 1. 72 nm), but only one of these domains inhibits cathepsin B (K(i) = 1. 67 nm) and cathepsin L (K(i) = 0.02 nm). Physical association of saxiphilin and papain blocked from turnover at the active-site cysteine residue can be detected by cross-linking with glutaraldehyde. The rate of association of saxiphilin and cathepsin B is strongly pH-dependent with an optimum at pH 5.2, reflecting control by at least two H(+)-titratable groups. These results further demonstrate that various Thyr-1 domains are selective inhibitors of cysteine proteinases with utility in the study of protein interactions and degradation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748022     DOI: 10.1074/jbc.M001406200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  A human protein containing multiple types of protease-inhibitory modules.

Authors:  M Trexler; L Bányai; L Patthy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

Review 3.  Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology.

Authors:  Bruno Di Jeso; Peter Arvan
Journal:  Endocr Rev       Date:  2015-11-23       Impact factor: 19.871

4.  Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion.

Authors:  Narendra V Sankpal; Taylor C Brown; Timothy P Fleming; John M Herndon; Anusha A Amaravati; Allison N Loynd; William E Gillanders
Journal:  BMC Cancer       Date:  2021-05-12       Impact factor: 4.430

5.  Determining the Advantages, Costs, and Trade-Offs of a Novel Sodium Channel Mutation in the Copepod Acartia hudsonica to Paralytic Shellfish Toxins (PST).

Authors:  Michael Finiguerra; David E Avery; Hans G Dam
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

6.  No evidence for induction or selection of mutant sodium channel expression in the copepod Acartia husdsonica challenged with the toxic dinoflagellate Alexandrium fundyense.

Authors:  Michael Finiguerra; David E Avery; Hans G Dam
Journal:  Ecol Evol       Date:  2014-08-22       Impact factor: 2.912

7.  A holistic approach to dissecting SPARC family protein complexity reveals FSTL-1 as an inhibitor of pancreatic cancer cell growth.

Authors:  Katrina Viloria; Amanda Munasinghe; Sharan Asher; Roberto Bogyere; Lucy Jones; Natasha J Hill
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

8.  Structure of the saxiphilin:saxitoxin (STX) complex reveals a convergent molecular recognition strategy for paralytic toxins.

Authors:  Tien-Jui Yen; Marco Lolicato; Rhiannon Thomas-Tran; J Du Bois; Daniel L Minor
Journal:  Sci Adv       Date:  2019-06-19       Impact factor: 14.136

Review 9.  Mechanisms Applied by Protein Inhibitors to Inhibit Cysteine Proteases.

Authors:  Livija Tušar; Aleksandra Usenik; Boris Turk; Dušan Turk
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

Review 10.  The Role of Cysteine Peptidases in Hematopoietic Stem Cell Differentiation and Modulation of Immune System Function.

Authors:  Milica Perišić Nanut; Urša Pečar Fonović; Tanja Jakoš; Janko Kos
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.